Default company panoramic image

Ex Vivo Dynamics

We are developing a platform device technology to improve the quality of blood for transfusions.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Brooklyn, NY, USA
  • Currency USD
  • Founded April 2013
  • Employees 4
  • Website

Company Summary

At Ex Vivo Dynamics we are developing a medical device platform to reduce the short-term and long-term complications resulting from blood transfusions by removing the damaging components at the bedside.These complications result in higher costs for the medical system and patients as well as increased mortality. We will sell our device to transfusion committees of hospitals through partnerships with existing relevant leaders in the marketplace .


  • Default avatar
    Alan Perlstein

    Alan is the founder & CEO of Ex Vivo Dynamics. He has 10 years of experience in research and development in biologics and devices.

  • Default avatar
    Ivy Saludes
    Business Development

    Ivy is currently the Business Development Advisor for Ex Vivo Dynamics.She has nearly ten years of professional experience advising start-ups and established companies in their growth strategies, strategic partnerships and capital raising. Ivy holds a Bachelor of Science (Biochemistry) from the State University of New York at Stony Brook, a Master of Public Administration (Health Insurance) from New York University and a Master of Business Admini

  • Default avatar
    Xi Huang
    Chief Technology Officer

    Dr. Xi Huang is currently the Chief Scientific Officer at Ex Vivo Dynamics. He was an Associate Professor of Medicine and Environmental Medicine at New York University School of Medicine for over 10 years.Dr. Huang received his Ph.D. in Toxicology and Applied Pharmacology. He has published over 70 journal articles and book chapters and has received over $10 million in government grants.

  • Default avatar
    Daisy Lobo
    Administrative Officer

    Daisy Lobo is the Administrative Officer at Ex Vivo Dynamics and will be working with the business related duties of the company and research activities of product development. She has a Bachelors and Masters degree in Biotechnology from Pune University ( INDIA) and is currently pursuing her Masters degree in Biotechnology and Entrepreneurship at NYU- Poly. She has research experience and knowledge in business concepts .

  • Default avatar
    Carlo Yuvienco

    Carlo has experience in material science and medical filter design.

  • Default avatar
    Samir Housri

    Samir is a principal of Rho Ventures. He has extensive experience in licensing and distribution, including contract negotiations, technical implementation and monetization.

  • Default avatar
    Sam Sia

    Dr. Sia is a professor at Columbia University and Founder of Harlem BIospace. He has extensive experience in diagnostic devices, microdevices, tissue engineering, bioengineering and translating scientific research into industry. He has successfully spun out 3 companies from his lab.

  • Default avatar
    John Galeazzi

    John is a serial entrepreneur and US army captain. With experience in medical device sales and business development.

  • Default avatar
    Steven Spitalnik
    Scientific Board

    Director of Laboratory Medicine at Columbia Medical Center with subspecialty interest and expertise in transfusion medicine.

    As Director of Clinical Laboratories at the CUMC campus of the NYPH, Dr. Spitalnik coordinates the clinical service, educational, and scholarly activities of the division.